Time course and spatial profile of Nogo-A expression in experimental autoimmune encephalomyelitis in C57BL/6 mice

Journal of Neuropathology and Experimental Neurology

Volumn 71, Issue 10, 2012, Pages 907-920

  Theotokis, Paschalis ^a   Lourbopoulos, Athanasios ^a   Touloumi, Olga ^a   Lagoudaki, Roza ^a   Kofidou, Evangelia ^a   Nousiopoulou, Evangelia ^a   Poulatsidou, Kyriaki Nepheli ^a   Kesidou, Evangelia ^a   Tascos, Nikolaos ^a   Spandou, Evangelia ^b   Grigoriadis, Nikolaos ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

^b ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

Author keywords

Axonopathy; Experimental autoimmune encephalomyelitis; GAP43; In situ hybridization; Kinetics; NgR; Nogo A

Indexed keywords

AMYLOID PRECURSOR PROTEIN; MESSENGER RNA; NEUROMODULIN; PROTEIN NOGO A;

ACUTE PHASE RESPONSE; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACUTE DISEASE; ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENE EXPRESSION REGULATION; GPI-LINKED PROTEINS; MICE; MICE, INBRED C57BL; MYELIN PROTEINS; NEURONS; OLIGODENDROGLIA; RECEPTORS, CELL SURFACE; TIME FACTORS;

EID: 84866732597     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e31826caebe     Document Type: Article

References (61)

1. Domeniconi M, Cao Z, Spencer T, et al. Myelin-Associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron 2002;35:283-90
2. Wang KC, Koprivica V, Kim JA, et al. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 2002;417:941-44 (Pubitemid 34716869)
3. Tan CL, Kwok JC, Patani R, et al. Integrin activation promotes axon growth on inhibitory chondroitin sulfate proteoglycans by enhancing integrin signaling. J Neurosci 2011;31:6289-95
4. Schwab ME. Functions of Nogo proteins and their receptors in the nervous system. Nat Rev Neurosci 2010;11:799-811
5. Fournier AE, GrandPre T, Strittmatter SM. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 2001;409: 341-46
6. Satoh J, Tabunoki H, Yamamura T, et al. TROY and LINGO-1 expression in astrocytes and macrophages/microglia in multiple sclerosis lesions. Neuropathol Appl Neurobiol 2007;33:99-107
7. Huber AB, Weinmann O, Brosamle C, et al. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J Neurosci 2002;22:3553-67
8. Nyatia E, Lang DM. Localisation and expression of a myelin associated neurite inhibitor, Nogo-A and its receptor Nogo-receptor by mammalian CNS cells. Res Vet Sci 2007;83:287-301
9. Richard M, Giannetti N, Saucier D, et al. Neuronal expression of Nogo-A mRNA and protein during neurite outgrowth in the developing rat olfactory system. Eur J Neurosci 2005;22:2145-58
10. Hunt D, Coffin RS, Prinjha RK, et al. Nogo-A expression in the intact and injured nervous system. Mol Cell Neurosci 2003;24:1083-102
11. Josephson A, Widenfalk J, Widmer HW, et al. NOGO mRNA expression in adult and fetal human and rat nervous tissue and in weight drop injury. Exp Neurol 2001;169:319-28
12. Liu H, Ng CE, Tang BL. Nogo-A expression in mouse central nervous system neurons. Neurosci Lett 2002;328:257-60
13. Tozaki H, Kawasaki T, Takagi Y, et al. Expression of Nogo protein by growing axons in the developing nervous system. Brain Res Mol Brain Res 2002;104:111-19
14. Buss A, Sellhaus B, Wolmsley A, et al. Expression pattern of NOGO-A protein in the human nervous system. Acta Neuropathol 2005;110: 113-19
15. Hasegawa T, Ohno K, Sano M, et al. The differential expression patterns of messenger RNAs encoding Nogo-A and Nogo-receptor in the rat central nervous system. Brain Res Mol Brain Res 2005;133:119-30
16. Josephson A, Trifunovski A, Widmer HR, et al. Nogo-receptor gene activity: Cellular localization and developmental regulation of mRNA in mice and humans. J Comp Neurol 2002;453:292-304
17. Bongiorno D, Petratos S. Molecular regulation of Nogo-A in neural cells: Novel insights into structure and function. Int J Biochem Cell Biol 2010; 42:1072-75
18. Lee JK, Zheng B. Role of myelin-Associated inhibitors in axonal repair after spinal cord injury. Exp Neurol 2012;235:33-42
19. Oertle T, Huber C, van der Putten H, et al. Genomic structure and functional characterisation of the promoters of human and mouse nogo/rtn4. J Mol Biol 2003;325:299-323
20. Kuhlmann T, Remington L, Maruschak B, et al. Nogo-A is a reliable oligodendroglial marker in adult human and mouse CNS and in demyelinated lesions. J Neuropathol Exp Neurol 2007;66:238-46
21. Schwab ME, Caroni P. Oligodendrocytes and CNS myelin are nonpermissive substrates for neurite growth and fibroblast spreading in vitro. J Neurosci 1988;8:2381-93
22. Chen MS, Huber AB, van der Haar ME, et al. Nogo-A is a myelinassociated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000;403:434-39
23. GrandPre T, Nakamura F, Vartanian T, et al. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 2000;403: 439-44
24. Prinjha R, Moore SE, Vinson M, et al. Inhibitor of neurite outgrowth in humans. Nature 2000;403:383-84
25. Grunewald E, Kinnell HL, Porteous DJ, et al. GPR50 interacts with neuronal NOGO-A and affects neurite outgrowth. Mol Cell Neurosci 2009;42:363-71
26. Montani L, Gerrits B, Gehrig P, et al. Neuronal Nogo-A modulates growth cone motility via Rho-GTP/LIMK1/cofilin in the unlesioned adult nervous system. J Biol Chem 2009;284:10793-807
27. Aloy EM, Weinmann O, Pot C, et al. Synaptic destabilization by neuronal Nogo-A. Brain Cell Biol 2006;35:137-56
28. Zagrebelsky M, Schweigreiter R, Bandtlow CE, et al. Nogo-A stabilizes the architecture of hippocampal neurons. J Neurosci 2010;30: 13220-34
29. Gianola S, Rossi F. Neurite-myelin interaction in the control of purkinje axon growth and regeneration. Ann N Y Acad Sci 2005;1048:141-48
30. Petrinovic MM, Duncan CS, Bourikas D, et al. Neuronal Nogo-A regulates neurite fasciculation, branching and extension in the developing nervous system. Development 2010;137:2539-50
31. Fontoura P, Ho PP, DeVoss J, et al. Immunity to the extracellular domain of Nogo-A modulates experimental autoimmune encephalomyelitis. J Immunol 2004;173:6981-92
32. Karnezis T, Mandemakers W, McQualter JL, et al. The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination. Nat Neurosci 2004;7:736-44
33. Yang Y, Liu Y, Wei P, et al. Silencing Nogo-A promotes functional recovery in demyelinating disease. Ann Neurol 2010;67:498-507
34. Hunt D, Coffin RS, Anderson PN. The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review. J Neurocytol 2002;31: 93-120
35. Satoh J, Onoue H, Arima K, et al. Nogo-A and nogo receptor expression in demyelinating lesions of multiple sclerosis. J Neuropathol Exp Neurol 2005;64:129-38
36. Grigoriadis N, Lourbopoulos A, Lagoudaki R, et al. Variable behavior and complications of autologous bone marrow mesenchymal stem cells transplanted in experimental autoimmune encephalomyelitis. Exp Neurol 2011;230:78-89
37. Lourbopoulos A, Grigoriadis N, Lagoudaki R, et al. Administration of 2-Arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis. Brain Res 2011;1390:126-41
38. Breitschopf H, Suchanek G, Gould RM, et al. In situ hybridization with digoxigenin-labeled probes: Sensitive and reliable detection method applied to myelinating rat brain. Acta Neuropathol 1992;84:581-87
39. Jones MV, Nguyen TT, Deboy CA, et al. Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis. J Neuroimmunol 2008;199:83-93
40. Fleming KK, Bovaird JA, Mosier MC, et al. Statistical analysis of data from studies on experimental autoimmune encephalomyelitis. J Neuroimmunol 2005;170:71-84
41. Dong HW. Allen Mouse Brain Atlas. Seattle (WA): Allen Institute for Brain Science, 2009
42. Willi R, Aloy EM, Yee BK, et al. Behavioral characterization of mice lacking the neurite outgrowth inhibitor Nogo-A. Genes Brain Behav 2009;8:181-92
43. Pernet V, Joly S, Christ F, et al. Nogo-A and myelin-Associated glycoprotein differently regulate oligodendrocyte maturation and myelin formation. J Neurosci 2008;28:7435-44
44. Mathis C, Schroter A, Thallmair M, et al. Nogo-A regulates neural precursor migration in the embryonic mouse cortex. Cereb Cortex 2010;20: 2380-90
45. Mingorance-Le Meur A, Zheng B, Soriano E, et al. Involvement of the myelin-Associated inhibitor Nogo-A in early cortical development and neuronal maturation. Cereb Cortex 2007;17:2375-86
46. O'Neill P, Whalley K, Ferretti P. Nogo and Nogo-66 receptor in human and chick: Implications for development and regeneration. Dev Dyn 2004;231:109-21
47. McDonald CL, Bandtlow C, Reindl M. Targeting the Nogo receptor complex in diseases of the central nervous system. Curr Med Chem 2011; 18:234-44
48. Hu F, Strittmatter SM. The N-Terminal domain of Nogo-A inhibits cell adhesion and axonal outgrowth by an integrin-specific mechanism. J Neurosci 2008;28:1262-69
49. Hunt D, Mason MR, Campbell G, et al. Nogo receptor mRNA expression in intact and regenerating CNS neurons. Mol Cell Neurosci 2002;20: 537-52
50. Wang X, Chun SJ, Treloar H, et al. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J Neurosci 2002;22;5505-15
51. Pradhan AD, Case AM, Farrer RG, et al. Dendritic spine alterations in neocortical pyramidal neurons following postnatal neuronal Nogo-A knockdown. Dev Neurosci 2010;32:313-20
52. Knyihar-Csillik E, Csillik B, Oestreicher AB. Light and electron microscopic localization of B-50 (GAP43) in the rat spinal cord during transganglionic degenerative atrophy and regeneration. J Neurosci Res 1992; 32:93-109
53. Bitsch A, Schuchardt J, Bunkowski S, et al. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 2000;123:1174-83
54. Herrero-Herranz E, Pardo LA, Gold R, et al. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: Implications for multiple sclerosis. Neurobiol Dis 2008;30:162-73
55. Benowitz LI, Routtenberg A. GAP-43: An intrinsic determinant of neuronal development and plasticity. Trends Neurosci 1997;20:84-91
56. Teunissen CE, Dijkstra CD, Jasperse B, et al. Growth-Associated protein 43 in lesions and cerebrospinal fluid in multiple sclerosis. Neuropathol Appl Neurobiol 2006;32:318-31
57. Nikic I, Merkler D, Sorbara C, et al. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 2011;17:495-99
58. Kerschensteiner M, Bareyre FM, Buddeberg BS, et al. Remodeling of axonal connections contributes to recovery in an animal model of multiple sclerosis. J Exp Med 2004;200:1027-38
59. Husseman J, Mehta RP. Management of synkinesis. Facial Plast Surg 2008;24:242-49
60. Merkler D, Metz GA, Raineteau O, et al. Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelinassociated neurite growth inhibitor Nogo-A. J Neurosci 2001;21:3665-73
61. Zorner B, Schwab ME. Anti-Nogo on the go: From animal models to a clinical trial. Ann N Y Acad Sci 2010;1198(Suppl 1):E22-34